标题
Tau Diagnostics and Clinical Studies
作者
关键词
-
出版物
JOURNAL OF MOLECULAR NEUROSCIENCE
Volume 63, Issue 2, Pages 123-130
出版商
Springer Nature
发表日期
2017-10-30
DOI
10.1007/s12031-017-0983-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tau Oligomers in Sera of Patients with Alzheimer’s Disease and Aged Controls
- (2017) Michala Kolarova et al. JOURNAL OF ALZHEIMERS DISEASE
- Quantitative neuropathology: an update on automated methodologies and implications for large scale cohorts
- (2017) Lauren Walker et al. JOURNAL OF NEURAL TRANSMISSION
- Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial
- (2017) Petr Novak et al. LANCET NEUROLOGY
- Advances in progressive supranuclear palsy: new diagnostic criteria, biomarkers, and therapeutic approaches
- (2017) Adam L Boxer et al. LANCET NEUROLOGY
- Inhibition of O-GlcNAcase leads to elevation of O-GlcNAc tau and reduction of tauopathy and cerebrospinal fluid tau in rTg4510 mice
- (2017) Nicholas B. Hastings et al. Molecular Neurodegeneration
- Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer’s disease dementia
- (2017) K Chiotis et al. MOLECULAR PSYCHIATRY
- ADNP/NAP dramatically increase microtubule end-binding protein–Tau interaction: a novel avenue for protection against tauopathy
- (2017) Y Ivashko-Pachima et al. MOLECULAR PSYCHIATRY
- Frontotemporal dementia with the V337M MAPT mutation
- (2017) Salvatore Spina et al. NEUROLOGY
- Expanding the cerebrospinal fluid endopeptidome
- (2017) Karl T. Hansson et al. PROTEOMICS
- Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy
- (2017) Kiran Yanamandra et al. Science Translational Medicine
- Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain
- (2017) Kok Pin Ng et al. Alzheimers Research & Therapy
- Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex
- (2017) Jorge Sepulcre et al. JAMA Neurology
- Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration
- (2017) K Höglund et al. Translational Psychiatry
- Premature primary tooth eruption in cognitive/motor-delayed ADNP-mutated children
- (2017) I Gozes et al. Translational Psychiatry
- Tau oligomers in cerebrospinal fluid in Alzheimer's disease
- (2017) Urmi Sengupta et al. Annals of Clinical and Translational Neurology
- The Eight and a Half Year Journey of Undiagnosed AD: Gene Sequencing and Funding of Advanced Genetic Testing Has Led to Hope and New Beginnings
- (2017) Illana Gozes et al. Frontiers in Endocrinology
- Tau: From research to clinical development
- (2016) David M. Holtzman et al. Alzheimers & Dementia
- In vivoimaging of neuromelanin in Parkinson’s disease using18F-AV-1451 PET
- (2016) Allan K. Hansen et al. BRAIN
- Tau-positive nuclear indentations in P301S tauopathy mice
- (2016) Marta Fernández-Nogales et al. BRAIN PATHOLOGY
- A Review of Treatment Options for Progressive Supranuclear Palsy
- (2016) Maria Stamelou et al. CNS DRUGS
- Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies
- (2016) Nicolas R. Barthélemy et al. JOURNAL OF ALZHEIMERS DISEASE
- Tau Proteins Cross the Blood-Brain Barrier
- (2016) William A. Banks et al. JOURNAL OF ALZHEIMERS DISEASE
- Human Truncated Tau Induces Mature Neurofibrillary Pathology in a Mouse Model of Human Tauopathy
- (2016) Ivana Zimova et al. JOURNAL OF ALZHEIMERS DISEASE
- Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)
- (2016) Abbas M. Walji et al. JOURNAL OF MEDICINAL CHEMISTRY
- Altered Proteins in the Aging Brain
- (2016) Adila Elobeid et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Sexual divergence in activity-dependent neuroprotective protein impacting autism, schizophrenia, and Alzheimer's disease
- (2016) Illana Gozes JOURNAL OF NEUROSCIENCE RESEARCH
- Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
- (2016) Serge Gauthier et al. LANCET
- Plasma tau in Alzheimer disease
- (2016) Niklas Mattsson et al. NEUROLOGY
- RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer’s disease: genome-wide transcriptomic profiling and bioinformatics data mining
- (2016) A Hadar et al. Translational Psychiatry
- Serum Fragments of Tau for the Differential Diagnosis of Alzheimer's Disease
- (2015) D. Inekci et al. Current Alzheimer Research
- Olfaction and Aging: A Mini-Review
- (2015) Johannes Attems et al. GERONTOLOGY
- The twenty-four KDa C-terminal tau fragment increases with aging in tauopathy mice: implications of prion-like properties
- (2015) Shin-Ei Matsumoto et al. HUMAN MOLECULAR GENETICS
- The Compassionate Side of Neuroscience: Tony Sermone’s Undiagnosed Genetic Journey—ADNP Mutation
- (2015) Illana Gozes et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease
- (2015) Sophie Sokolow et al. JOURNAL OF NEUROCHEMISTRY
- Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy
- (2015) Asami Kondo et al. NATURE
- Tau in physiology and pathology
- (2015) Yipeng Wang et al. NATURE REVIEWS NEUROSCIENCE
- Genome-wide association study of corticobasal degeneration identifies risk variants shared with progressive supranuclear palsy
- (2015) Naomi Kouri et al. Nature Communications
- Role of the Tau N-terminal region in microtubule stabilization revealed by new endogenous truncated forms
- (2015) Maxime Derisbourg et al. Scientific Reports
- Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer’s pathologies
- (2015) A Malishkevich et al. Translational Psychiatry
- Alzheimer's disease
- (2015) Colin L. Masters et al. Nature Reviews Disease Primers
- Divergent CSF alterations in two common tauopathies: Alzheimer's disease and progressive supranuclear palsy
- (2014) D. Wagshal et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
- (2014) Adam L Boxer et al. LANCET NEUROLOGY
- Pharmacological inhibition of O-GlcNAcase (OGA) prevents cognitive decline and amyloid plaque formation in bigenic tau/APP mutant mice
- (2014) Scott A Yuzwa et al. Molecular Neurodegeneration
- The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins
- (2014) S Oz et al. MOLECULAR PSYCHIATRY
- A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
- (2014) Eduardo Tolosa et al. MOVEMENT DISORDERS
- Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial
- (2014) Günter U. Höglinger et al. MOVEMENT DISORDERS
- Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease
- (2014) Zhentao Zhang et al. NATURE MEDICINE
- Novel Marker for the Onset of Frontotemporal Dementia: Early Increase in Activity-Dependent Neuroprotective Protein (ADNP) in the Face of Tau Mutation
- (2014) Yulie Schirer et al. PLoS One
- A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment
- (2013) Bruce H. Morimoto et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: Protection against impairments in axonal transport
- (2013) Yan Jouroukhin et al. NEUROBIOLOGY OF DISEASE
- Effects of Davunetide on N-acetylaspartate and Choline in Dorsolateral Prefrontal Cortex in Patients with Schizophrenia
- (2013) L Fredrik Jarskog et al. NEUROPSYCHOPHARMACOLOGY
- An Enzyme-Generated Fragment of Tau Measured in Serum Shows an Inverse Correlation to Cognitive Function
- (2013) Kim Henriksen et al. PLoS One
- Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s Disease
- (2013) Jere E. Meredith Jr. et al. PLoS One
- D-NAP Prophylactic Treatment in the SOD Mutant Mouse Model of Amyotrophic Lateral Sclerosis: Review of Discovery and Treatment of Tauopathy
- (2012) Yan Jouroukhin et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Activity-dependent neuroprotector homeobox protein: A candidate protein identified in serum as diagnostic biomarker for Alzheimer's disease
- (2012) Ming-Hui Yang et al. Journal of Proteomics
- The ADNP Derived Peptide, NAP Modulates the Tubulin Pool: Implication for Neurotrophic and Neuroprotective Activities
- (2012) Saar Oz et al. PLoS One
- Microtubules (tau) as an Emerging Therapeutic Target: NAP (Davunetide)
- (2011) Illana Gozes CURRENT PHARMACEUTICAL DESIGN
- Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
- (2011) Juan Manuel Domínguez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
- (2011) Günter U Höglinger et al. NATURE GENETICS
- Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia
- (2011) Daniel C. Javitt et al. SCHIZOPHRENIA RESEARCH
- Rational therapeutic approaches to progressive supranuclear palsy
- (2010) M. Stamelou et al. BRAIN
- Tau Pathology and Future Therapeutics
- (2010) I. Gozes Current Alzheimer Research
- In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: A DTI study using TBSS
- (2010) Susanne Knake et al. MOVEMENT DISORDERS
- Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practice
- (2010) Illana Gozes EPMA Journal
- Addressing Alzheimers Disease Tangles: From NAP to AL-108
- (2009) Illana Gozes et al. Current Alzheimer Research
- NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model
- (2009) Natalia Shiryaev et al. NEUROBIOLOGY OF DISEASE
- Direct analysis of tau from PSP brain identifies new phosphorylation sites and a major fragment of N-terminally cleaved tau containing four microtubule-binding repeats
- (2008) Selina Wray et al. JOURNAL OF NEUROCHEMISTRY
- A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer's Disease
- (2008) Y. Matsuoka et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started